A Chinese herbal medicine used to treat heart disease has been licensed for sale in the Netherlands, making it the first Chinese medicine to receive marketing authorisation in a Western market since the European Directive on Traditional Herbal Medicinal Products came into effect in 2011

    • Please note: The rest of this article is only available to subscribers of the Journal of Chinese medicine. Please subscribe now.

Categories: Herbal medicine

Not yet subscribed?

Subscribe to the Journal of Chinese Medicine now from only £30.00 per year. Your subscription will include:

Subscribe now